ArticleJNMA; journal of the Nepal Medical Association2021

Tofacitinib as an Adjunct Immunomodulator for Treatment of a Patient with Severe COVID-19: A Case Report.

Gentle Sunder Shrestha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.